Drug Approval | April 26, 2022
GSK launches once daily, single inhaler-triple therapy for COPD patients
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
_256_275.jpg)